Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RET | P07949 | 1/20 | 0.48 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.48 |
| ▸ | CAMK1D | Q8IU85 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30226116 | 1.00 | RET (0.48) | RETMAPK14CAMK1DHDAC6EPHX2 | |
| SCHEMBL23359376 | 1.00 | RET (0.48) | RETMAPK14CAMK1DHDAC6EPHX2 | |
| SCHEMBL23359371 | 1.00 | RET (0.48) | RETMAPK14CAMK1DHDAC6EPHX2 | |
| SCHEMBL20735243 | 0.80 | RET (0.50) | RETMAPK14CAMK1DHDAC6EPHX2 | |
| SCHEMBL15665354 | 0.75 | RET (0.45) | RETMAPK14CAMK1DHDAC6EPHX2 | |
| SCHEMBL15665353 | 0.75 | RET (0.45) | RETMAPK14CAMK1DHDAC6EPHX2 | |
| SCHEMBL7549733 | 0.75 | RET (0.45) | RETMAPK14CAMK1DHDAC6EPHX2 | |
| SCHEMBL14484239 | 0.75 | RET (0.45) | RETMAPK14CAMK1DHDAC6EPHX2 | |
| SCHEMBL16656381 | 0.73 | RET (0.51) | RETMAPK14CAMK1DHDAC6EPHX2 | |
| SCHEMBL9426196 | 0.72 | RET (0.49) | RETMAPK14CAMK1DHDAC6EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110520404-B | Alpha alkylation of aldehydes with polycyclic olefins | 弗门尼舍有限公司 | 2023-02-07 | — | — | CN | disclosed |
| EP-3612510-B1 | ALPHA ALKYLATION OF ALDEHYDE WITH A POLYCYCLIC OLEFIN | FIRMENICH & CIE (CH) | 2022-07-06 | — | — | EP | disclosed |
| US-11319272-B2 | Alpha alkylation of aldehyde with a polycyclic olefin | FIRMENICH SA (CH) | 2022-05-03 | — | — | US | disclosed |
| US-20210147328-A1 | ALPHA ALKYLATION OF ALDEHYDE WITH A POLYCYCLIC OLEFIN | FIRMENICH SA (CH) | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11319272-B2 | Alpha alkylation of aldehyde with a polycyclic olefin | AKR1C3, ADH1A, ADH1C | RET 3305/4885MAPK14 3339/4885CAMK1D 4307/4885 |
| US-20210147328-A1 | ALPHA ALKYLATION OF ALDEHYDE WITH A POLYCYCLIC OLEFIN | AKR1C3, ADH1A, ADH1C | RET 3305/4885MAPK14 3339/4885CAMK1D 4307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.